title: Community-acquired pneumonia by Legionella pneumophila. Do we need to include new recommendations for inflammatory bowel disease patients under immunomodulators?
abstract: We present the case of a community-acquired pneumonia by Legionella Pneumophila in a 31-year-old patient with Crohn's disease under anti-TNF agents. Following this and other similar cases reported in literature, we propose to include recommendations to prevent this infection in patients starting treatment with immunosuppressant drugs through simple measures regarding the control of water in the patients' home.
authors.affiliation: Digestivo, H.C.U. Virgen de la Arrixaca, España.
authors.forename: Tania
authors.initials: T
authors.lastname: Fernández Llamas
authors.affiliation: Aparato Digestivo, H.C.U. Virgen de la Arrixaca.
authors.forename: Antonio
authors.initials: A
authors.lastname: Sánchez Torres
authors.affiliation: Unidad de Gestión Clínica de Digestivo, Hospital Clínico Universitario Virgen de la Arrixa, España.
authors.forename: Juan
authors.initials: J
authors.lastname: Egea Valenzuela
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy*; D000069285:Infliximab / Q000009:adverse effects / Q000627:therapeutic use; D007877:Legionnaires' Disease / Q000150:complications* / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D007155:Immunologic Factors; D000069285:Infliximab